Beauty Health CO 8-K filings

The Beauty Health Company's shareholders approved amendments to declassify the board of directors and eliminate the supermajority voting requirement at the 2024 annual meeting.

The Beauty Health Company reported a 5.7% decrease in net sales for the first quarter of 2024, but improved profitability through cost management and debt repurchases.

The Beauty Health Company's Chief Operating Officer, Brad Hauser, has mutually terminated his employment, effective April 9, 2024, and will transition to an advisory role until no later than June 30, 2024, with a separation package including $400,000 in severance pay.

The Beauty Health Company's Chief Operating Officer, Brad Hauser, will depart on April 9, 2024, transitioning to an advisory role until June 30, 2024.

The Beauty Health Company has formalized Marla Beck's appointment as CEO with a new employment agreement, while also amending its executive severance plan and disclosing an SEC subpoena.

BeautyHealth's full year net sales reached $398 million, an 8.8% increase year-over-year, while fourth quarter sales declined slightly by 1.3% to $96.8 million.

The Beauty Health Company has officially named Marla Beck as its President and Chief Executive Officer, following her tenure as Interim CEO.